InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Smith Christopher M, Chairman & CEO. Officer active across 2 companies, notably Ortho Clinical Diagnostics Holdings plc. In total, 6 disclosures have been recorded. Total volume traded: €3.8m. The latest transaction was disclosed on 3 January 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
34,554 shares
Common Stock
SEC:0000899243-22-020478:0·
367,360 shares
Ordinary Shares, $0.00001 par value
SEC:0000899243-22-020381:0·
€1m100,000 shares@ €11.043336.5% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-22-001678·
€1m100,000 shares@ €11.043318.3% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-22-001678:0·
€2m103,213 shares@ €18.611363.5% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-21-049757·
€2m103,213 shares@ €18.611331.7% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-21-049757:0·
6 of 6 declarations
About Smith Christopher M
Christopher M. Smith is the Chairman and CEO and Board Member of Ortho Clinical Diagnostics Holdings plc and QuidelOrtho Corp. He leads these companies with a strategic vision focused on innovation and improving healthcare. Under his leadership, Ortho Clinical Diagnostics and QuidelOrtho are committed to providing quality diagnostic solutions. Christopher M. Smith is recognized for his expertise in the diagnostics sector.
